KP Tissue Inc. (TSE:KPT – Free Report) – Equities research analysts at Desjardins cut their Q4 2024 earnings estimates for shares of KP Tissue in a research report issued to clients and investors on Wednesday, November 13th. Desjardins analyst F. Tremblay now anticipates that the company will post earnings per share of $0.18 for the quarter, down from their prior forecast of $0.19. The consensus estimate for KP Tissue’s current full-year earnings is $0.44 per share. Desjardins also issued estimates for KP Tissue’s FY2025 earnings at $0.72 EPS.
Separately, TD Securities raised their price target on KP Tissue from C$8.50 to C$9.00 and gave the company a “hold” rating in a report on Wednesday, August 14th.
KP Tissue Price Performance
Shares of KPT stock opened at C$8.30 on Monday. The company’s fifty day simple moving average is C$8.33 and its two-hundred day simple moving average is C$8.38. KP Tissue has a 52 week low of C$7.99 and a 52 week high of C$9.72. The stock has a market cap of C$82.75 million, a P/E ratio of 13.83, a PEG ratio of -0.88 and a beta of 0.37.
KP Tissue Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, October 15th. Stockholders of record on Tuesday, October 15th were given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 8.67%. The ex-dividend date was Friday, September 27th. KP Tissue’s dividend payout ratio is 120.00%.
About KP Tissue
KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins.
Read More
- Five stocks we like better than KP Tissue
- How to Invest in Insurance Companies: A GuideĀ
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Most active stocks: Dollar volume vs share volume
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Stock Analyst Ratings and Canadian Analyst Ratings
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.